![Jennifer Fitzpatrick](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jennifer Fitzpatrick
General Counsel bei
SIONNA THERAPEUTICS, INC.
Vermögen: 339 278 $ am 31.08.2026
Profil
Jennifer Fitzpatrick is Chief Legal Officer at Sionna Therapeutics, Inc. starting in 2025.
Former positions include Secretary & Director at Aegerion Pharmaceuticals, Inc., Vice President & Corporate Counsel at SAGE Therapeutics, Inc., Corporate Counsel at Revvity, Inc., and Corporate Counsel at AVEO Pharmaceuticals, Inc. Education includes undergraduate studies at Middlebury College and graduate studies at the University of Virginia School of Law.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 17.09.2026 | 56 265 ( 0,12 % ) | 339 278 $ | 31.08.2026 |
Aktive Positionen von Jennifer Fitzpatrick
| Unternehmen | Position | Beginn |
|---|---|---|
| SIONNA THERAPEUTICS, INC. | General Counsel | 03.06.2024 |
Ehemalige bekannte Positionen von Jennifer Fitzpatrick
| Unternehmen | Position | Ende |
|---|---|---|
| REVVITY, INC. | General Counsel | - |
| SAGE THERAPEUTICS, INC. | Corporate Officer/Principal | - |
| AVEO PHARMACEUTICALS, INC. | General Counsel | - |
| AEGERION PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | - |
Ausbildung von Jennifer Fitzpatrick
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
23
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Revvity, Inc.
 Revvity, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes reagents, analytical instruments and develops software | Health Technology |
Aegerion Pharmaceuticals, Inc.
 Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for hyperlipidemia and metabolic diseases | Health Technology |
Middlebury College
 Middlebury College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AVEO Pharmaceuticals, Inc.
 AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops cancer therapeutics | Health Technology |
SAGE Therapeutics, Inc.
 SAGE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel medicines for central nervous system disorders | Health Technology |
University of Virginia School of Law
 University of Virginia School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sionna Therapeutics, Inc.
 Sionna Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for CF and rare diseases | Health Technology |
